A plethora of companies are trying to change the way women are supported, are treated, and take care of themselves. Ashkan Afkhami Managing Director and Partner • Progress and momentum in the women’s health • Alternative care models and new entrants will space will continue as they have in recent years. appear. Companies such as CVS, Walgreens, and A plethora of companies are trying to change the way Walmart will build on their existing infrastructure to women are supported, are treated, and take care of provide community-based health services and explore themselves. We are especially excited to see positive channels for providing near-real-time care through trends in fertility options (such as those offered by innovative new technologies and services. Other compa- Ovia Health and Progyny), community-based care nies, such as Amazon (following its recent acquisition of (Cayabacre), support for underserved populations One Medical), will leverage their strategic assets to move (Sesh Groups), care advocacy (Maven), alternative birth into holistic health care, including work that focuses on options (Oula Health), and mental health services that sleep, activity, and nutrition. are uniquely designed for women (Caraway Health). In addition, both large companies and startups will make • The need for outcome-based solutions backed strong pushes for women’s health equity in different by real-world evidence and studies will pose a countries around the world in order to provide better stronger barrier to entry into digital health. Over experiences and options. We look forward to additional the past decade, we have seen various organizations— attention, investment, and innovation in the women’s such as Omada, Proteus Digital Health, WellDoc, health space in 2023. Akili Interactive, and Pear Therapeutics—take digital solutions to market, with mixed outcomes. As a result, although CPT/ICD (procedural and diagnostic) codes are available for remote patient monitoring and other clinical services, manufacturers within the pharmaceu- tical and medical-device sectors, along with payers and providers, will require more evidence before they adopt or reimburse such digital health solutions.